PHOTO
- 75-year legacy of helping people live healthier lives in Saudi Arabia
Riyadh: — Leading healthcare company Abbott was the official sponsor for this year’s Saudi Food and Drug Authority Conference and Exhibition (SFDACE). The conference theme was “Consumer Engagement and Consumer-Centered Regulations” and took place between September 30 and October 2, 2019 in Riyadh.
Through this sponsorship, Abbott aimed at maintaining and enhancing its presence in the Kingdom and highlighting its extensive range of innovative healthcare products. This goes in line with the advances introduced in the Ministry of Health's strategic health plan, as part of Saudi Vision 2030.
Abbott General Manager in KSA Imad Mousa said, “We were delighted to participate in the SFDACE event for the third consecutive year. Our aim is to continue to support the Kingdom's strategic health plan and work alongside the Ministry of Health in order to raise healthcare standards. We are proud of our long history in the Kingdom which extends over more than 75 years. During this time, we have introduced a wide range of life-changing technologies and products that have played an important role in improving people’s lives.”
Abbott had a dedicated booth at the SFDA’s exhibition where it showcased its latest innovative medical solutions. The company also participated in panel discussions and workshops, discussing medical devices clinical trials and highlighting the latest medical technology that protects patients.
Dr. Yana Pozhidaeva, Associate Director Clinical Quality Assurance at Abbott gave a workshop on Generation of Clinical Evidence for Medical Devices, whereas Samir Shah, Divisional Vice President for Software Product Development gave a presentation on Cardiac Device Cybersecurity - Commitment to Patient Protection.
Abbott has been a fervent advocate of the Saudization program and takes pride in hiring and nurturing promising Saudi talents. As part of its commitment to Saudization, 40% of the company’s medical representatives who joined its Pharmaceuticals division this year were Saudis, with plans to have a 100% Saudi sales force within the division by 2021.
The company also launched a University Relations program, with four different universities and colleges across the kingdom, namely King Abdulaziz University and Batterjee Medical College in Jeddah, as well as King Saud University and Princess Noura University in Riyadh. By virtue of the program, Abbott collaborates with these academic institutions to hold summer training programs and yearly internship waves for students to increase their awareness of potential career options in the healthcare sector.
Besides, in 2016 Abbott launched the “Abbott Foundation Program,” a six-month curriculum designed to help fresh Saudi graduates start a new career. Today, the company takes pride in being acclaimed a Top Employer in Saudi Arabia for 2017, 2018 and 2019.
-Ends-
About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.
Connect with us at arabia.abbott, on LinkedIn at www.linkedin.com/company/abbott-/ , on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.
Media: Alberto Chahoud, alberto.chahoud@abbott.com
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
